This view is further supported by the fact that many previous studies trying to correlate systemic bloodstream levels of IGF1 and cancer have remained inconclusive [62,63,64], while, on the contrary, high IGF-II blood levels have been often reported to be associated with a variety of solid cancers [63,65,66]. The gene discussed is IGF2; the disease is cancer.